Intermountain Healthcare, a Utah-based nonprofit system of 22 hospitals and 185 clinics, is compiling the cumulative radiation patients receive from about 220,000 higher-dose procedures and imaging exams each year, starting with exams performed in the last quarter of 2012. That information is now readily available to both physicians and patients.

Unavoidable damage caused to the heart and lungs by radiotherapy treatment of tumors in the chest region can be limited by the administration of an ACE inhibitor, a drug commonly used in the treatment of cardiovascular disease, a group of Dutch researchers have found. [1]

M-Files Inc. said Elekta is deploying M-Files in the cloud to more effectively manage quality documentation and related processes for several key aspects of its global business.

Magnetic resonance imaging (MRI) measurements of atrophy in an important area of the brain are an accurate predictor of multiple sclerosis (MS), according to a new study published online in the journal Radiology. According to the researchers, these atrophy measurements offer an improvement over current methods for evaluating patients at risk for MS.

InSightec Ltd. announced that the U.S. Centers for Medicare & Medicaid Services (CMS), a federal agency within the U.S. Department of Health and Human Services (HHS), has created a new billing code for magnetic resonance (MR) guided focused ultrasound treatment of pain palliation of metastatic bone lesions and has established a Medicare payment rate for hospital outpatient departments.

At an event held at Hospital for Special Surgery, GE Healthcare introduced Mavric SL, a novel magnetic resonance (MR) imaging technique designed to address the growing clinical need to more accurately image soft tissue and bone in patients with MR conditional-labeled implants, such as joint replacements and other instrumentation. According to a Hospital for Special Surgery study published in The Journal of Bone & Joint Surgery, MR imaging can detect inflammation of the joint lining (synovitis) in patients with metal-on-metal hip implants long before symptoms appear, allowing for a more conclusive diagnosis and effective planning for follow-up care.

New hope for cancer patients is building in North Texas as construction begins on the $105 million Texas Center for Proton Therapy, the first proton therapy center in the Dallas-Fort Worth Metroplex. The center, spearheaded by healthcare leaders Texas Oncology, The U.S. Oncology Network and McKesson Specialty Health, will have capacity to treat more than 100 patients per day when it opens in 2016.

Facilitating collaboration between radiologic technologists and radiologists to improve patient care, communication and quality improvement is one of the key safety recommendations outlined in a new white paper from the ASRT Foundation.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now